Skip to main content

Effectiveness of repeat surgery for recurrence after primary hepatectomy in patients with intrahepatic cholangiocarcinoma

Abstract

Background

Intrahepatic cholangiocarcinoma (IHCC) has a poor prognosis, and surgery remains the only effective treatment. However, tumor recurrence after primary hepatectomy is common. We examined the significance of repeat surgery for IHCC.

Methods

We collected data for all patients with IHCC between 1992 and 2018 (n = 67) in our database. Fifty-three (79.1%) of all 67 patients experienced recurrence after primary hepatectomy and we analyzed data for those 53 recurrent patients. We divided recurrent patients into a repeat surgery group (n = 9), chemotherapy group (n = 19), and best supportive care group (n = 25). We analyzed differences in patients’ clinicopathological factors, including prognosis, between the three groups.

Results

The IHCC recurrence rate after hepatectomy in our institution was 79.1%. Of the 53 patients with recurrence, nine underwent repeat surgery (17.0%). The characteristics of the patients undergoing repeat surgery was lower stage at primary hepatectomy. Recurrence sites in the repeat surgery group were liver (n = 6), lung (n = 2), and adrenal gland (n = 1), as a single nodule. The period between primary hepatectomy and recurrence was comparatively longer in the repeat surgery group, at 1.8 years. The prognosis in patients undergoing repeat surgery was significantly better compared with the other groups. Not undergoing repeat surgery (hazard ratio: 5.506; p = 0.0077) and positive lymph node metastasis (hazard ratio: 2.207; p = 0.0242) were independent poor prognostic factors.

Conclusions

Repeat surgery should be considered in patients with IHCC with a single recurrence site and negative lymph node metastasis at primary surgery and at least more than 6 months of disease-free period after primary surgery.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2

References

  1. Bridgewater J, Galle PR, Khan SA et al (2014) Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol 60:1268–1289

    Article  Google Scholar 

  2. Yamada M, Arimoto A, Touoda Y et al (2019) Long-term survival after surgical resection for recurrent hepatic and pulmonary metastases of intrahepatic cholangiocarcinoma: a case report. Surg Case Rep 5:135

    Article  Google Scholar 

  3. Hyder O, Hatzaras I, Sotiropoulos GC et al (2013) Recurrence after operative management of intrahepatic cholangiocarcinoma. Surgery 153:811–818

    Article  Google Scholar 

  4. Mavros MN, Economopoulos KP, Alexiou VG et al (2014) Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis. JAMA Surg 149:565–574

    Article  Google Scholar 

  5. Chan K-M, Tsai C-Y, Yeh C-N et al (2018) Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence. BMC Gastroenterol 18:180

    Article  Google Scholar 

  6. Yamashita Y-I, Shirabe K, Beppu T et al (2017) Surgical management of recurrent intrahepatic cholangiocarcinoma: predictors, adjuvant chemotherapy, and surgical therapy for recurrence: a multi-institutional study by the Kyushu Study Group of Liver Surgery. Ann Gastroenterol Surg 1:136–142

    Article  Google Scholar 

  7. Morine Y, Shimada M, Imura S et al (2009) Usefulness of gemcitabine combined with 5-fluorouracil and cisplatin (GFP) in patients for unresectable biliary carcinoma. Hepatogastroenterology 56:307–312

    CAS  PubMed  Google Scholar 

  8. Souche R, Addeo P, Oussoultzoglou E et al (2016) First and repeat liver resection for primary and recurrent intrahepatic cholangiocarcinoma. Am J Surg 212:221–229

    Article  Google Scholar 

  9. Si A, Li J, Xing X et al (2017) Effectiveness of repeat hepatic resection for patients with recurrent intrahepatic cholangiocarcinoma: factors associated with long-term outcomes. Surgery 161:897–908

    Article  Google Scholar 

  10. Park HM, Yun SP, Lee EC et al (2016) Outcomes for patients with recurrent intrahepatic cholangiocarcinoma after surgery. Ann Surg Oncol 23:4392–4400

    Article  Google Scholar 

  11. Spolverato G, Kim Y, Alexandrescu S et al (2016) Management and outcomes of patients with recurrent intrahepatic cholangiocarcinoma following previous curative-intent surgical resection. Ann Surg Oncol 23:235–243

    Article  Google Scholar 

  12. Zhang SJ, Hu P, Wang N et al (2013) Thermal ablation versus repeated hepatic resection for recurrent intrahepatic cholangiocarcinoma. Ann Surg Oncol 20:3596–3602

    Article  Google Scholar 

  13. Liver cancer study group of Japan (2015) General rules for the clinical and pathological study of primary liver cancer. Jpn Digestive Dis. 33(6):765–770

    Article  Google Scholar 

  14. Morise Z, Sugioka A, Tokoro T et al (2010) Surgery and chemotherapy for intrahepatic cholangiocarcinoma. World J Hepatol 2:58–64

    Article  Google Scholar 

  15. De Jong MC, Nathan H, Sotiropoulos GC et al (2011) Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol 29:3140–3145

    Article  Google Scholar 

  16. Ohtsuka M, Ito H, Kimura F et al (2003) Extended hepatic resection and outcomes in intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 10:259–264

    Article  Google Scholar 

  17. Uenishi T, Yamazaki O, Horii KT et al (2006) A long-term survivor of intrahepatic cholangiocarcinoma with paraaortic lymph node metastasis. J Gastroenterol 41:391–392

    Article  Google Scholar 

  18. Higuchi R, Yamamoto M, Hatori T et al (2006) Intrahepatic cholangiocarcinoma with lymph node metastasis successfully treated by immunotherapy with CD3-activated T cells and dendritic cells after surgery: report of a case. Surg Today 36:559–562

    Article  Google Scholar 

  19. Morine Y, Shimada M (2015) The value of systematic lymph node dissection for intrahepatic cholangiocarcinoma from the viewpoint of liver lymphatics. J Gastroenterol 50:913–927

    CAS  Article  Google Scholar 

  20. Morine Y, Shimada M, Imura S et al (2012) Clinical impact of lymph node dissection in surgery for peripheral-type intrahepatic cholangiocarcinoma. Surg Today 42:147–151

    Article  Google Scholar 

  21. Ercolani G, Vetrone G, Grazi GL et al (2010) Intrahepatic cholangiocarcinoma: primary liver resection and aggressive multimodal treatment of recurrence significantly prolong survival. Ann Surg 252:107–114

    Article  Google Scholar 

  22. Yang J, Yan LN (2008) Current status of intrahepatic cholangiocarcinoma. World J Gastroenterol 14:6289–6297

    Article  Google Scholar 

  23. Kitamura K, Hatano E, Higashi T et al (2011) Prognostic value of 18 F-fluorodeoxyglucose positron emission tomography in patients with extrahepatic bile duct cancer. J Hepatobiliary Pancreat Sci 18:39–46

    Article  Google Scholar 

  24. Yamamoto M, Takasaki K, Otsubo T et al (2001) Recurrence after surgical resection of intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 8:154–157

    CAS  Article  Google Scholar 

  25. Saiura A, Yamamoto J, Kokudo N et al (2011) Intrahepatic cholangiocarcinoma: analysis of 44 consecutive resected cases including 5 cases with repeat resections. Am J Surg 201:203–208

    Article  Google Scholar 

  26. Kitano Y, Yamashita Y, Nakagawa S et al (2020) Effectiveness of surgery for recurrent cholangiocarcinoma: a single center experience and brief literature review. Am J Surg 219:175–180

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Yuji Morine.

Ethics declarations

Conflicts of interest

The authors disclose no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Verify currency and authenticity via CrossMark

Cite this article

Tokuda, K., Morine, Y., Saito, Y. et al. Effectiveness of repeat surgery for recurrence after primary hepatectomy in patients with intrahepatic cholangiocarcinoma. Int J Clin Oncol 25, 2083–2089 (2020). https://doi.org/10.1007/s10147-020-01775-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-020-01775-x

Keywords

  • Intrahepatic cholangiocarcinoma
  • Recurrence
  • Repeat surgery